Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Implantable subcutaneous infusion ports

L T Soh1, P T Ang

  • 1Department of Medical Oncology, Singapore General Hospital.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.

Gynecologic oncology·2005
Same author

Efficacy and tolerability of irinotecan in patients with advanced colorectal cancer in Singapore.

Annals of the Academy of Medicine, Singapore·2002
Same author

The relevance of oncogenes as prognostic markers in cervical cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2002
Same author

Uterine leiomyosarcoma--a Singapore experience.

The Australian & New Zealand journal of obstetrics & gynaecology·2001
Same author

Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer.

Cancer chemotherapy and pharmacology·2000
Same author

Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.

Acta oncologica (Stockholm, Sweden)·2000
Same journal

Exploring the network structure and lived experiences of preoperative fear in patients with esophageal cancer: a convergent mixed-methods study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Substance use monitoring in supportive oncology: surveillance is not a clinical outcome, and policing is not a therapeutic framework.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

From loss to meaning: therapeutic group processes in parental grief after pediatric cancer.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Challenges in postoperative self-management for patients with bladder cancer and urinary stoma: a qualitative study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Building a comparative evidence framework for breakthrough cancer pain.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Financial toxicity among breast cancer survivors receiving care during the pandemic.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
See all related articles

Subcutaneous infusion ports offer reliable vascular access for cancer patients, simplifying chemotherapy and other treatments. This method proved safe and effective, with minimal complications like wound issues and thrombosis.

Area of Science:

  • Oncology
  • Vascular Surgery
  • Medical Devices

Background:

  • Limited vascular access is a significant challenge in cancer care, impacting treatment delivery.
  • Repeated venous cannulation causes psychological distress for patients undergoing cancer therapy.
  • Subcutaneous infusion ports offer a solution for consistent and convenient vascular access.

Purpose of the Study:

  • To evaluate the efficacy and safety of subcutaneous infusion ports in cancer patients.
  • To assess the complication rates associated with port implantation and use.
  • To determine the suitability of infusion ports for chemotherapy and blood product administration.

Main Methods:

  • Port implantation in 22 cancer patients for venous access (17) and regional chemotherapy (5).

Related Experiment Videos

  • Monitoring of indwelling periods ranging from 70 to 470 days (median 270 days).
  • Documentation of complications including wound dehiscence, venous thrombosis, and subcutaneous hematoma.

    • Main Results:

    • Two patients (9%) experienced wound dehiscence requiring revision; one necessitated port removal.
    • Complications included venous thrombosis (5%) and subcutaneous hematoma (5%).
    • No instances of catheter-related bacteraemia were reported, indicating a low infection risk.

    Conclusions:

    • Subcutaneous infusion ports provide a suitable and effective means of vascular access for cancer patients.
    • The procedure demonstrated a favorable safety profile with manageable complications.
    • Infusion ports enhance treatment delivery and patient comfort during cancer therapy.